{"transactions":[{"id":1919233,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2023-04-17T21:27:57.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":27936,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-23-024499","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024499/doc4.xml","form_type":"4"}},{"id":1919232,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2023-04-17T21:27:57.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-23-024499","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024499/doc4.xml","form_type":"4"}},{"id":1919231,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2023-04-17T21:27:57.000Z","date":"2023-04-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":2012,"price":2.88,"value":5794.56,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":46648,"source":{"system":"sec-edgar","filing":"0001209191-23-024499","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024499/doc4.xml","form_type":"4"}},{"id":1919230,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2023-04-17T21:27:57.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":48660,"source":{"system":"sec-edgar","filing":"0001209191-23-024499","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024499/doc4.xml","form_type":"4"}},{"id":1919229,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2023-04-17T21:27:57.000Z","date":"2023-04-13","kind":"exercise","planned":false,"acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":44096,"source":{"system":"sec-edgar","filing":"0001209191-23-024499","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123024499/doc4.xml","form_type":"4"}},{"id":2050107,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Performance Stock Units","published_at":"2023-01-20T22:09:27.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":66385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 25, 2022, the Compensation Committee of the Issuer (the \"Committee\") granted the Reporting Person Performance Stock Units (\"PSUs\"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 25, 2022, the Compensation Committee of the Issuer (the \"Committee\") granted the Reporting Person Performance Stock Units (\"PSUs\"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs are further subject to a time-based vesting schedule. The PSUs will vest in full on the first anniversary of the grant date subject to continued employment through such date. Upon vesting and settlement of the PSUs, the Reporting Person will receive a number of shares of common stock of the Issuer equal to the number of PSUs that have vested."}],"balance_after":66385,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":66385},"source":{"system":"sec-edgar","filing":"0001209191-23-004302","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123004302/doc4.xml","form_type":"4"}},{"id":2054179,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2023-01-17T22:36:01.000Z","date":"2023-01-13","kind":"exercise","acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":32500,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-23-003562","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003562/doc4.xml","form_type":"4"}},{"id":2054178,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2023-01-17T22:36:01.000Z","date":"2023-01-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":8750,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-23-003562","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003562/doc4.xml","form_type":"4"}},{"id":2054177,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2023-01-17T22:36:01.000Z","date":"2023-01-13","kind":"tax_withholding","acquired":false,"shares":2012,"price":3.17,"value":6378.04,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":42846,"source":{"system":"sec-edgar","filing":"0001209191-23-003562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003562/doc4.xml","form_type":"4"}},{"id":2054176,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2023-01-17T22:36:01.000Z","date":"2023-01-13","kind":"exercise","acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":44858,"source":{"system":"sec-edgar","filing":"0001209191-23-003562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003562/doc4.xml","form_type":"4"}},{"id":2054175,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2023-01-17T22:36:01.000Z","date":"2023-01-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":40294,"source":{"system":"sec-edgar","filing":"0001209191-23-003562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919123003562/doc4.xml","form_type":"4"}},{"id":2136689,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2022-10-17T20:37:23.000Z","date":"2022-10-13","kind":"exercise","acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":37064,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-22-053834","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053834/doc4.xml","form_type":"4"}},{"id":2136688,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2022-10-17T20:37:23.000Z","date":"2022-10-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-22-053834","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053834/doc4.xml","form_type":"4"}},{"id":2136687,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2022-10-17T20:37:23.000Z","date":"2022-10-13","kind":"tax_withholding","acquired":false,"shares":2012,"price":3.76,"value":7565.12,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":39044,"source":{"system":"sec-edgar","filing":"0001209191-22-053834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053834/doc4.xml","form_type":"4"}},{"id":2136686,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2022-10-17T20:37:23.000Z","date":"2022-10-13","kind":"exercise","acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":41056,"source":{"system":"sec-edgar","filing":"0001209191-22-053834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053834/doc4.xml","form_type":"4"}},{"id":2136685,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2022-10-17T20:37:23.000Z","date":"2022-10-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":36492,"source":{"system":"sec-edgar","filing":"0001209191-22-053834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122053834/doc4.xml","form_type":"4"}},{"id":2201576,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-07-27T22:22:45.000Z","date":"2022-07-25","kind":"grant","acquired":true,"shares":165961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 8 equal quarterly installments beginning one quarter after the date of grant (07/25/2022)."}],"balance_after":165961,"derivative":{"exercise_price":3.17,"expiration_date":"2032-07-25","underlying":"Common Stock","underlying_shares":165961},"source":{"system":"sec-edgar","filing":"0001209191-22-043291","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122043291/doc4.xml","form_type":"4"}},{"id":2207297,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2022-07-15T20:56:35.000Z","date":"2022-07-13","kind":"exercise","acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":41628,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-22-042261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042261/doc4.xml","form_type":"4"}},{"id":2207296,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2022-07-15T20:56:35.000Z","date":"2022-07-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":11250,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-22-042261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042261/doc4.xml","form_type":"4"}},{"id":2207295,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2022-07-15T20:56:35.000Z","date":"2022-07-13","kind":"tax_withholding","acquired":false,"shares":2012,"price":3.01,"value":6056.12,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":35242,"source":{"system":"sec-edgar","filing":"0001209191-22-042261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042261/doc4.xml","form_type":"4"}},{"id":2207294,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2022-07-15T20:56:35.000Z","date":"2022-07-13","kind":"exercise","acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":37254,"source":{"system":"sec-edgar","filing":"0001209191-22-042261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042261/doc4.xml","form_type":"4"}},{"id":2207293,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2022-07-15T20:56:35.000Z","date":"2022-07-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":32690,"source":{"system":"sec-edgar","filing":"0001209191-22-042261","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122042261/doc4.xml","form_type":"4"}},{"id":2296654,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2022-04-15T21:04:38.000Z","date":"2022-04-13","kind":"exercise","acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021)."}],"balance_after":46192,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-22-024521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024521/doc4.xml","form_type":"4"}},{"id":2296653,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2022-04-15T21:04:38.000Z","date":"2022-04-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":12500,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-22-024521","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024521/doc4.xml","form_type":"4"}},{"id":2296652,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2022-04-15T21:04:38.000Z","date":"2022-04-13","kind":"tax_withholding","acquired":false,"shares":2012,"price":6.07,"value":12212.84,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":31440,"source":{"system":"sec-edgar","filing":"0001209191-22-024521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024521/doc4.xml","form_type":"4"}},{"id":2296651,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2022-04-15T21:04:38.000Z","date":"2022-04-13","kind":"exercise","acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":33452,"source":{"system":"sec-edgar","filing":"0001209191-22-024521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024521/doc4.xml","form_type":"4"}},{"id":2296650,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2022-04-15T21:04:38.000Z","date":"2022-04-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":28888,"source":{"system":"sec-edgar","filing":"0001209191-22-024521","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122024521/doc4.xml","form_type":"4"}},{"id":2435414,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2022-01-14T22:07:49.000Z","date":"2022-01-13","kind":"exercise","acquired":false,"shares":4564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."}],"balance_after":50756,"derivative":{"underlying":"Common Stock","underlying_shares":4564},"source":{"system":"sec-edgar","filing":"0001209191-22-003361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003361/doc4.xml","form_type":"4"}},{"id":2435413,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2022-01-14T22:07:49.000Z","date":"2022-01-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":13750,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-22-003361","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003361/doc4.xml","form_type":"4"}},{"id":2435412,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2022-01-14T22:07:49.000Z","date":"2022-01-13","kind":"tax_withholding","acquired":false,"shares":2012,"price":8.3,"value":16699.6,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":27638,"source":{"system":"sec-edgar","filing":"0001209191-22-003361","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003361/doc4.xml","form_type":"4"}},{"id":2435411,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2022-01-14T22:07:49.000Z","date":"2022-01-13","kind":"exercise","acquired":true,"shares":4564,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":29650,"source":{"system":"sec-edgar","filing":"0001209191-22-003361","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003361/doc4.xml","form_type":"4"}},{"id":2435410,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2022-01-14T22:07:49.000Z","date":"2022-01-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":25086,"source":{"system":"sec-edgar","filing":"0001209191-22-003361","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919122003361/doc4.xml","form_type":"4"}},{"id":2460251,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2021-12-23T23:59:44.000Z","date":"2021-10-29","kind":"other","acquired":true,"shares":817,"price":9.3585,"value":7645.8945,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on October 29, 2021."}],"balance_after":23836,"source":{"system":"sec-edgar","filing":"0001209191-21-071173","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121071173/doc4.xml","form_type":"4"}},{"id":2542016,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2021-10-15T20:24:49.000Z","date":"2021-10-13","kind":"grant","acquired":true,"shares":55320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant."}],"balance_after":55320,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":55320},"source":{"system":"sec-edgar","filing":"0001209191-21-060550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060550/doc4.xml","form_type":"4"}},{"id":2542015,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-10-15T20:24:49.000Z","date":"2021-10-13","kind":"grant","acquired":true,"shares":92200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests and becomes exercisable monthly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that the stock option will be fully vested on the four year anniversary of the date of grant."}],"balance_after":92200,"derivative":{"exercise_price":10.55,"expiration_date":"2031-10-13","underlying":"Common Stock","underlying_shares":92200},"source":{"system":"sec-edgar","filing":"0001209191-21-060550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060550/doc4.xml","form_type":"4"}},{"id":2542014,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2021-10-15T20:24:49.000Z","date":"2021-10-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020)."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-21-060550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060550/doc4.xml","form_type":"4"}},{"id":2542013,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2021-10-15T20:24:49.000Z","date":"2021-10-13","kind":"tax_withholding","acquired":false,"shares":433,"price":10.55,"value":4568.15,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":23019,"source":{"system":"sec-edgar","filing":"0001209191-21-060550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060550/doc4.xml","form_type":"4"}},{"id":2542012,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2021-10-15T20:24:49.000Z","date":"2021-10-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":23452,"source":{"system":"sec-edgar","filing":"0001209191-21-060550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121060550/doc4.xml","form_type":"4"}},{"id":2633546,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2021-07-15T20:49:39.000Z","date":"2021-07-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."}],"balance_after":16250,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-21-046789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046789/doc4.xml","form_type":"4"}},{"id":2633545,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2021-07-15T20:49:39.000Z","date":"2021-07-13","kind":"tax_withholding","acquired":false,"shares":433,"price":13.48,"value":5836.84,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":22202,"source":{"system":"sec-edgar","filing":"0001209191-21-046789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046789/doc4.xml","form_type":"4"}},{"id":2633544,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2021-07-15T20:49:39.000Z","date":"2021-07-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":22635,"source":{"system":"sec-edgar","filing":"0001209191-21-046789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046789/doc4.xml","form_type":"4"}},{"id":2633543,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2021-07-15T20:49:39.000Z","date":"2021-04-30","kind":"other","acquired":true,"shares":971,"price":13.8975,"value":13494.4725,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2021."}],"balance_after":21385,"source":{"system":"sec-edgar","filing":"0001209191-21-046789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121046789/doc4.xml","form_type":"4"}},{"id":2748983,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2021-04-15T20:53:32.000Z","date":"2021-04-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."}],"balance_after":17500,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-21-026843","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026843/doc4.xml","form_type":"4"}},{"id":2748982,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2021-04-15T20:53:32.000Z","date":"2021-04-13","kind":"tax_withholding","acquired":false,"shares":433,"price":16.66,"value":7213.78,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":20414,"source":{"system":"sec-edgar","filing":"0001209191-21-026843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026843/doc4.xml","form_type":"4"}},{"id":2748981,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2021-04-15T20:53:32.000Z","date":"2021-04-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":20847,"source":{"system":"sec-edgar","filing":"0001209191-21-026843","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121026843/doc4.xml","form_type":"4"}},{"id":2906638,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2021-01-15T21:27:30.000Z","date":"2021-01-13","kind":"exercise","acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020)."}],"balance_after":18750,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001209191-21-003798","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121003798/doc4.xml","form_type":"4"}},{"id":2906637,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2021-01-15T21:27:30.000Z","date":"2021-01-13","kind":"tax_withholding","acquired":false,"shares":433,"price":18.16,"value":7863.28,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions."}],"balance_after":19597,"source":{"system":"sec-edgar","filing":"0001209191-21-003798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121003798/doc4.xml","form_type":"4"}},{"id":2906636,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2021-01-15T21:27:30.000Z","date":"2021-01-13","kind":"exercise","acquired":true,"shares":1250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":20030,"source":{"system":"sec-edgar","filing":"0001209191-21-003798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919121003798/doc4.xml","form_type":"4"}},{"id":2933804,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Common Stock","published_at":"2020-12-23T21:24:41.000Z","date":"2020-10-30","kind":"other","acquired":true,"shares":637,"price":11.6535,"value":7423.2795,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on October 30, 2020."}],"balance_after":18780,"source":{"system":"sec-edgar","filing":"0001209191-20-065016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120065016/doc4.xml","form_type":"4"}},{"id":3006593,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Restricted Stock Units","published_at":"2020-10-15T20:24:39.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-054908","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120054908/doc4.xml","form_type":"4"}},{"id":3006592,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CCO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-10-15T20:24:39.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant."}],"balance_after":170000,"derivative":{"exercise_price":15.72,"expiration_date":"2030-10-13","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001209191-20-054908","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919120054908/doc4.xml","form_type":"4"}},{"id":3333113,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-12-23T21:29:19.000Z","date":"2019-12-19","kind":"grant","acquired":true,"shares":55562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant."}],"balance_after":55562,"derivative":{"exercise_price":25.02,"expiration_date":"2029-12-19","underlying":"Common Stock","underlying_shares":55562},"source":{"system":"sec-edgar","filing":"0001209191-19-061796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919119061796/doc4.xml","form_type":"4"}},{"id":3397628,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-10-04T23:56:53.000Z","date":"2019-10-03","kind":"purchase","acquired":true,"shares":5143,"price":17.5,"value":90002.5,"ownership":{"direct":true},"balance_after":18143,"source":{"system":"sec-edgar","filing":"0001209191-19-052611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919119052611/doc4.xml","form_type":"4"}},{"id":3460331,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-07-17T12:48:51.000Z","date":"2019-07-15","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest and become exercisable with respect to 75,000 shares on the first anniversary of his first day of employment (the \"Grant\nDate\"), followed by 225,000 shares vesting ratably each month over the subsequent three years, such that 300,000 options will be fully\nvested on the four year anniversary of the Grant Date."}],"balance_after":300000,"derivative":{"exercise_price":18.29,"expiration_date":"2029-07-15","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-19-042303","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919119042303/doc4.xml","form_type":"4"}},{"id":3514150,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-23T12:39:39.000Z","date":"2019-05-22","kind":"purchase","acquired":true,"shares":3000,"price":17.55,"value":52650.0,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001209191-19-032198","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919119032198/doc4.xml","form_type":"4"}},{"id":3728046,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-19T01:06:00.000Z","date":"2018-12-15","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":24.97,"exercise_date":"2019-12-15","expiration_date":"2028-12-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-18-063347","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118063347/doc4.xml","form_type":"4"}},{"id":3728045,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-19T01:06:00.000Z","date":"2018-12-15","kind":"grant","acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":19500,"derivative":{"exercise_price":24.97,"expiration_date":"2028-12-15","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001209191-18-063347","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118063347/doc4.xml","form_type":"4"}},{"id":3776730,"issuer":{"id":162645,"kind":"organization","name":"SENOMYX INC","symbol":"SNMX"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-11-02T18:12:50.000Z","date":"2018-11-02","kind":"disposition_to_issuer","acquired":false,"shares":363000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $1.50 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $1.50 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":1.05,"expiration_date":"2028-03-14","underlying":"Common Stock","underlying_shares":363000},"source":{"system":"sec-edgar","filing":"0001209191-18-057004","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1123979/000120919118057004/doc4.xml","form_type":"4"}},{"id":3776729,"issuer":{"id":162645,"kind":"organization","name":"SENOMYX INC","symbol":"SNMX"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-11-02T18:12:50.000Z","date":"2018-11-02","kind":"disposition_to_issuer","acquired":false,"shares":417000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $1.50 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was cancelled in the Merger in exchange for a cash payment equal to $1.50 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":1.02,"expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":417000},"source":{"system":"sec-edgar","filing":"0001209191-18-057004","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1123979/000120919118057004/doc4.xml","form_type":"4"}},{"id":3776728,"issuer":{"id":162645,"kind":"organization","name":"SENOMYX INC","symbol":"SNMX"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-11-02T18:12:50.000Z","date":"2018-11-02","kind":"other","acquired":false,"shares":108293,"price":1.5,"value":162439.5,"ownership":{"direct":false,"nature":"By family trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger (the \"Merger Agreement\"), dated September 16, 2018, among the Issuer, Firmenich Incorporated, a Delaware corporation (\"Parent\"), and Sentry Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\") in exchange for a cash consideration of $1.50 per share, without interest, subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"shares","element":"transactionShares","label":"F4","text":"Includes 25,772 shares of Common Stock that were acquired by the Reporting Person on 8/31/18 pursuant to the Issuer's Employee Stock Purchase Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Disposed of pursuant to an Agreement and Plan of Merger (the \"Merger Agreement\"), dated September 16, 2018, among the Issuer, Firmenich Incorporated, a Delaware corporation (\"Parent\"), and Sentry Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\") in exchange for a cash consideration of $1.50 per share, without interest, subject to any applicable withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Prior reports erroneously reflected all shares as indirectly held by trust, when a portion of the shares were actually directly held by the insider as reflected herein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-057004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123979/000120919118057004/doc4.xml","form_type":"4"}},{"id":3776727,"issuer":{"id":162645,"kind":"organization","name":"SENOMYX INC","symbol":"SNMX"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-11-02T18:12:50.000Z","date":"2018-11-02","kind":"other","acquired":false,"shares":111469,"price":1.5,"value":167203.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger (the \"Merger Agreement\"), dated September 16, 2018, among the Issuer, Firmenich Incorporated, a Delaware corporation (\"Parent\"), and Sentry Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\") in exchange for a cash consideration of $1.50 per share, without interest, subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Disposed of pursuant to an Agreement and Plan of Merger (the \"Merger Agreement\"), dated September 16, 2018, among the Issuer, Firmenich Incorporated, a Delaware corporation (\"Parent\"), and Sentry Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\") in exchange for a cash consideration of $1.50 per share, without interest, subject to any applicable withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the \"Merger\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Prior reports erroneously reflected all shares as indirectly held by trust, when a portion of the shares were actually directly held by the insider as reflected herein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-057004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123979/000120919118057004/doc4.xml","form_type":"4"}},{"id":3986544,"issuer":{"id":162645,"kind":"organization","name":"SENOMYX INC","symbol":"SNMX"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock option (right to buy)","published_at":"2018-03-21T18:52:59.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":363000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option was granted on 03/15/2018.  The option vests over four years with 1/4 of the total number of shares subject to the option vesting on the first anniversary of the date of grant and 1/48th of the total number of shares subject to the option vesting monthly thereafter, until fully vested on 03/15/2022."}],"balance_after":363000,"derivative":{"exercise_price":1.05,"expiration_date":"2028-03-14","underlying":"Common Stock","underlying_shares":363000},"source":{"system":"sec-edgar","filing":"0001437749-18-005186","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123979/000143774918005186/rdgdoc.xml","form_type":"4"}},{"id":3986543,"issuer":{"id":162645,"kind":"organization","name":"SENOMYX INC","symbol":"SNMX"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-03-21T18:52:59.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":15545,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Although not required, the Reporting Person has elected to report 15,545 shares acquired by the Reporting Person on 2/28/18 pursuant to the Issuer's Employee Stock Purchase Plan"}],"balance_after":193990,"source":{"system":"sec-edgar","filing":"0001437749-18-005186","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123979/000143774918005186/rdgdoc.xml","form_type":"4"}},{"id":4125518,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-20T21:18:01.000Z","date":"2017-12-18","kind":"grant","acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":19500,"derivative":{"exercise_price":17,"expiration_date":"2027-12-18","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001209191-17-066634","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919117066634/doc4.xml","form_type":"4"}},{"id":4373741,"issuer":{"id":162645,"kind":"organization","name":"SENOMYX INC","symbol":"SNMX"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-03-23T19:04:54.000Z","date":"2017-03-23","kind":"purchase","acquired":true,"shares":15000,"price":0.9867,"value":14800.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9787 to $0.9928, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of this amount, 108,293 shares of common stock are held indirectly by a trust."}],"balance_after":158293,"source":{"system":"sec-edgar","filing":"0001437749-17-005154","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123979/000143774917005154/rdgdoc.xml","form_type":"4"}},{"id":4373740,"issuer":{"id":162645,"kind":"organization","name":"SENOMYX INC","symbol":"SNMX"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-03-23T19:04:54.000Z","date":"2017-03-22","kind":"purchase","acquired":true,"shares":35000,"price":0.9779,"value":34226.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9576 to $0.9995, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Of this amount, 108,293 shares of common stock are held indirectly by a trust."}],"balance_after":143293,"source":{"system":"sec-edgar","filing":"0001437749-17-005154","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123979/000143774917005154/rdgdoc.xml","form_type":"4"}},{"id":4380375,"issuer":{"id":162645,"kind":"organization","name":"SENOMYX INC","symbol":"SNMX"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock option (right to buy)","published_at":"2017-03-17T16:51:13.000Z","date":"2017-03-15","kind":"grant","acquired":true,"shares":417000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option was granted on 03/15/2017.  The option vests over four years with 1/4 of the total number of shares subject to the option vesting on the first anniversary of the date of grant and 1/48th of the total number of shares subject to the option vesting monthly thereafter, until fully vested on 03/15/2021."}],"balance_after":417000,"derivative":{"exercise_price":1.02,"expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":417000},"source":{"system":"sec-edgar","filing":"0001437749-17-004848","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123979/000143774917004848/rdgdoc.xml","form_type":"4"}},{"id":4380374,"issuer":{"id":162645,"kind":"organization","name":"SENOMYX INC","symbol":"SNMX"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-03-17T16:51:13.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":7990,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Although not required, the Reporting Person has elected to report 7,990 shares acquired by the Reporting Person on 2/28/17 pursuant to the Issuer's Employee Stock Purchase Plan"}],"balance_after":108293,"source":{"system":"sec-edgar","filing":"0001437749-17-004848","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123979/000143774917004848/rdgdoc.xml","form_type":"4"}},{"id":4484565,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-23T21:29:58.000Z","date":"2017-01-19","kind":"purchase","acquired":true,"shares":10000,"price":12.2,"value":122000.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-17-005086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919117005086/doc4.xml","form_type":"4"}},{"id":4512838,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":114429,"kind":"person","name":"POYHONEN JOHN","position":1,"cik":"0001286100","reported_name":"POYHONEN JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-23T21:07:25.000Z","date":"2016-12-21","kind":"grant","acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant."}],"balance_after":19500,"derivative":{"exercise_price":13,"expiration_date":"2026-12-21","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001209191-16-156665","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919116156665/doc4.xml","form_type":"4"}}]}